1.A Clinical Study on the Incompetent Internal Os of the Cervix.
Sun Hee NAM ; K T JANG ; Sin Jung OH ; Jae Gun SUNWOO ; Dong Han BAE
Korean Journal of Perinatology 1997;8(1):32-42
This study was undertaken for the clinical analysis and evaluation on 121 patients with incompetent internal os of the cervix, who were admitted and treated with McDonald operation or Shirodkar operation at the Soonchounhyang Medical Center from January 1991 to December 1995. The results of this study were as follows : 1. The incidence of this IIOC was 1.1% of 11,116 cases of total delivery. 2. The mean age of IIOC was 31.7 years old. 3. The average number of gravida was 3.2. 4. The most common contributary factor was previous history of artificial abortion (51.2 %), and midtrimester abortion (17.4 %), cervical laceration due to previous vaginal delivery (8.3 %) etc. was followed. 5. The success rate of operation was 76 %, and the highest success rate (85.7 %) was reveald with period from 15th weeks to 16th weeks of gestation. 6. When cervical dilatation was abscent or small, the success rate of operation was high. 7. The factors of failed operation were preterm labor (58.7 %), PROM (34.5 %), and PIH, bleeding. 8. The delivery method after operation was vaginal delivery in 83 cases (68.6%) and cesarean section in 38 cases (31.4 %).
Cervix Uteri*
;
Cesarean Section
;
Female
;
Hemorrhage
;
Humans
;
Incidence
;
Labor Stage, First
;
Lacerations
;
Obstetric Labor, Premature
;
Pregnancy
;
Pregnancy Trimester, Second
2.A Case of 9p-Syndrome due to a Balanced Maternal Translocation t(9;16) (p22;p13.2).
Kyeong Hee KIM ; Sang Dong SIN ; Jin Yeong HAN ; Jung Man KIM ; Lisa G SHAFFER
Korean Journal of Clinical Pathology 1997;17(4):676-680
The deletion 9p syndrome is a well characterized syndrome with about one hundred cases having been reported. Most patients have dysmorphic facial features, cardiac anomalies, and mental retardation. We report on a female infant with micrognathia, corneal opacity, cleft palace, cardiac anomaly, left polycystic kidney, and deletion 9p. Chromosome analysis and fluorescence in situ hybridization (FISH) showed her to have a derived chromosome 9 inherited from a maternal t(9;16) (p22;p13.2) by adjacent I segregation There are few reports of this particular chromosome rearrangement. We review deletion Sp syndrome.
Chromosomes, Human, Pair 9
;
Corneal Opacity
;
Female
;
Fluorescence
;
Humans
;
In Situ Hybridization
;
Infant
;
Intellectual Disability
;
Polycystic Kidney Diseases
4.Severe hypophosphatemia in hospitalized patients.
Sin Ju KANG ; Jee Yoon KIM ; Hyun Jin PARK ; Duk Hee HAN ; Byung Hee YU ; Sung Soo MOON
Korean Journal of Nephrology 1991;10(3):330-335
No abstract available.
Humans
;
Hypophosphatemia*
5.Periodic Alternating Nystagmus Associated with Chiari-1 Malformation and Syringomyelia.
Sueng Han HAN ; Jae In JUNG ; Hee Sun KIM ; Sin Jeong JIN
Journal of the Korean Ophthalmological Society 1999;40(1):283-286
Periodic alternating nystagmus(PAN) is a form of spontaneous nystagmus with a specific pattern. It may be of congenital origin in many cases, and may be related to vestibulo-cerebellar system disease. It usually causes not only many ophthalmic problems such as decreased vision but also neurologic symptoms such as ataxic gait. So, ophthalmologist must perform both ophthalmic and neurologic examinations. Nystagmus can be treated with muscle relaxant. We report our experience about 30-year-old woman who complained of involuntary ocular movement and ataxic gait, and were diagnosed as PAN associated with Chiari-1 malformation and syringomyelia through electronystagmography and brain MRF.
Adult
;
Brain
;
Electronystagmography
;
Female
;
Gait
;
Humans
;
Neurologic Examination
;
Neurologic Manifestations
;
Nystagmus, Pathologic*
;
Syringomyelia*
6.Pervalence of sensiticity to aspirin (ASA) and food additives in subjects diagnosed as having intrinsic asthma.
Hae Sim PARK ; Yo Han CHO ; Sun Sin KIM ; Hee Yeon KIM ; Dong Ho NAHM ; Chang Hee SUH ; Myung Ho HAHN
Journal of Asthma, Allergy and Clinical Immunology 1998;18(4):662-671
Objective and METHOD: In order to identify the aggravating agents for intrinsic asthma, we performed ASA- and food additive-challenge tests on 182 subjects diagnosed as having intrinsic asthma. The following tests were performed: Lysine-aspirin bronchoprovocation test to confirm aspirin-sensitivity, sodium bi-sulfite (40-200mg) oral provocation test for sulfite sensitivity, tartrazine oral provocation test (50mg) for tartrazine sensitivity, and sodium benzoate (400mg) oral provocation test for sodium benzoate sensitivity. Positive reaction was defined as decrease in FEV, by more than 20% from the baseline value after the provocation. RESULT: Seventy-five (41.2%) of 182 subjects showed positive responses to more than one agent among the aspirin and three food additives challenged. The prevalence of aspirin-sensitivity was the highest (22.5%), followed by sulfite-sensitivity (8.8%), and then concurrent sensitivity to both aspirin and sulfite (6.0% ), to both aspirin and tartrazine (1.6% ), to aspirin, sulfite and tartrazine (1.1%) and to aspirin, sulfite and sodium benzoate (0.5%). Rhino-sinusitis was noted in 62.5% of aspirin-sensitive asthmatic subjects, 60% of sulfite-sensitive ones, and 80% of tartrazine-sensitive ones. Urticaria was noted in 21.4% of aspirin-sensitive asthmatic subjects, 16.6% of sulfite-sensitive ones and 6.3% of tartrazine-sensitive ones. Thirty-seven to 83% of positive responders had no adverse reaction history. CONCLUSION: These findings suggest that ASA and food additive challenge tests should be considered as a screening test to evaluate any aggravating factors in subjects with intrinsic asthma, even though they may not have experienced any adverse reactions.
Aspirin*
;
Asthma*
;
Food Additives*
;
Mass Screening
;
Prevalence
;
Sodium
;
Sodium Benzoate
;
Tartrazine
;
Urticaria
7.Prognostic Factors of Invasive Fungal Sinusitis.
Myung Chul LEE ; Jae Jin SONG ; Han Sin JUNG ; Seung Sin LEE ; Chae Seo RHEE ; Chul Hee LEE ; Yang Gi MIN
Korean Journal of Otolaryngology - Head and Neck Surgery 2003;46(10):841-845
BACKGROUND AND OBJECTIVES: Fulminant invasive fungal sinusitis (IFS) is an aggressive, destructive disease most commonly affecting the immunocompromised hosts. This study aimed to investigate the clinical features of invasive fungal sinusitis and to determine its prognostic factors. MATERIALS AND METHOD: Fifteen cases of invasive fungal sinusitis were retrospectively reviewed. Prognosis was analyzed according to predisposing factors including the underlying disease, the extent of disease, the mycotic species, and treatment modalities. RESULTS: Overall 5-year survival rate of the patients with IFS was 60%. There was significant survival gain in the group for which underlying disease was well controlled (p=0.04). There was no difference in survival in terms of mycotic species and extent of disease at presentation. No statistically significant difference in survival was observed between the conservative surgery and the radical surgery group. CONCLUSION: Survival is usually determined at the very early period of treatment. The most important prognostic factor is not the surgical modalities including wide surgical resection or conservative debridement, but the optimal control of underlying disease.
Causality
;
Debridement
;
Fibrinogen
;
Humans
;
Immunocompromised Host
;
Prognosis
;
Retrospective Studies
;
Sinusitis*
;
Survival Rate
8.Expandable metallic stents: An experimental study in the nasolacrimal system of dogs.
Ho Young SONG ; Jeong Min LEE ; Young Min HAN ; Eui Il HWANG ; Gyung Ho CHUNG ; Myung Hee SIN ; Chong Soo KIM ; Ki Chul CHOI
Journal of the Korean Radiological Society 1993;29(6):1109-1115
Balloon dacryocystoplasty has been reported to be a safe, easy and effective nonoperative treatment for nasolacrimal stenosis. The results were not encouraging, however, because of its high failure and recurrence rates. To evaluate the feasibility of using modified Gianturco expandable metallic stents for maintenance of the dilated nasolacrimal system(NLS), 20 stents of 3 mm in diameter and 10mm long were placed in 20 nasolacrimal ducts of 10 dogs for 1 month to 10 months. It was more difficult to introduce the stents into the proximal portion(A) of the NLS than into the distal portion(B) due to the narrow and bony canal of the A portion. Twenty stents showed no migration in follow-up studies of up to 10 months. One complete occlusion occurred in a stent placed in A portion. Autopsy studies showed stents were covered with epithelium within 2 months after placement. Our experience suggest that the placement of Gianturco self-expandable stents may be a useful method of dilating and maintaining the luminal diameter of the NLS, although care must be taken to select the proper stent size.
Animals
;
Autopsy
;
Constriction, Pathologic
;
Dogs*
;
Epithelium
;
Follow-Up Studies
;
Methods
;
Nasolacrimal Duct
;
Phenobarbital
;
Recurrence
;
Stents*
9.Serum IgG and IgG subclass in bronchial asthma.
Sun Sin KIM ; Hae Sim PARK ; Hee Yeon KIM ; Dong Ho NAHM ; Dong Suk HAN ; Soo Keol LEE ; Jae Ok LEE ; Yun Sik KWAK
Journal of Asthma, Allergy and Clinical Immunology 1999;19(6):927-934
BACKGROUND AND OBJECTIVE: IgG subclass deficiency has been reported in patients with bronchial asthma and is associated with recurrent respiratory tract infections. This study was done to identify prevalence of IgG subclass deficiency and to evaluate the possible difference between atopic and non-atopic asthmatics. Subjects and METHODS: We measured serum levels of IgG and IgG subclass in 35 asthmatic patients and 50 healthy controls using nephelometry. Reference values of each IgG subclass was defined as cumulative percentile between 2.5% to 97.5% of controls. RESULTS: Total IgG, IgG1 and IgG2 of asthmatics were significantly lower than for those of controls(p<0.05, respectively). In atopic asthmatics, compared with non-atopic asthmatics, IgG4 level was significantly higher (p<0.05). The frequency of IgG subclass levels below the reference value was eight (22.9%) of 35 asthmatics. CONCLUSION: IgG, IgG1 and IgG2 were significantly lower in asthmatic patients. Some patients had IgG subclass levels below reference value. Further studies will be needed to evaluate their clinical significance.
Asthma*
;
Humans
;
Immunoglobulin G*
;
Nephelometry and Turbidimetry
;
Prevalence
;
Reference Values
;
Respiratory Tract Infections
10.Testicular Involvement in Childhood Acute Lymphoblastic Leukemia.
Hyeon Jin PARK ; Hyoung Jin KANG ; Jun Ah LEE ; Hyo Jeong HAN ; Hyoung Soo CHOI ; Ki Woong SUNG ; Eun Sun TOO ; Hee Toung SIN ; Hyo Seop AHN
Korean Journal of Pediatric Hematology-Oncology 1997;4(2):301-309
BACKGROUND: The testes are one of the most common extramedullary sites of relapse in boys with acute lymphoblastic leukemia(ALL). The reported incidence of isolated testicular relapse varies from 3 to 40%. If these patients are treated exclusively with testicular irradialion, a systemic relapse occurs within a few months. Recently, the use of intensive chemotherapy and testicular irradiation improved the survival rate for boys with testicular leukemia. So, we performed this study to identify clinical manifestations, disease free survival and prognostic factors of testicular leukemia in children. METHODS: We reviewed 33 patients of testicular leukemia among total 410 boys with ALL diagnosed at the Department of Pediatrics, Seoul National University Children's Hospital from Jan. 1970 to Aug. 1996. Testicular leukemia was confirmed by testicular biopsy in all 33 patients. These patients were treated with combined local testicular irradiation(2,400~2,500 cGy/8~12fractions) and systemic chemotherapy. Two patients, in whom testicular relapse was diagnosed before 1979, unilateral orchiectomy of the involved site and testicular irradiation of the opposite site were performed. Probability estimates of disease free survival (DFS) were calculated by the method of Kaplan and Meier, and the relationship of prognostic factors to DFS was compared using the chi-square test in survival analysis. RESULTS: In 410 boys with ALL, testicular leukemia occurred in 33 patients(8%). Of 33 patients, 6 patients presented with testicular involvement at initial diagnosis, 16 patients had testicular relapse while still receiving chemotherapy and 11 patients had testicular relapse 3 to 57 months(median : 15 months) after cessation of chemotherapy. The median age of 33 patients was 7.4 yrs(9 months~18 yrs) and median WBC count 7,600/ L(2,700~270,000/L). All patients presented with painless testicular enlargement and testicular leukemia was confirmed by testicular biopsy. Among 33 patients, 2 had prior CNS relapse and 11 had concomitant bone marrow and/or CNS relapse. Twenty nine patients were treated with combined local testicular irradiation and systemic chemotherapy. Eleven had second relapse(6 bone marrow, 3 CNS, 2 opposite testis). Seventeen have been followed until now: 6 patients on chemotherapy and 11 patients(37.9%) in complete remission for 48.5+/-22.3 months(19~86 months). The 3 year DFS for 29 patients was 55.3%+/-10.1%. The following prognostic factors showed no significant association with DFS in testicular relapse : age and WBC count at initial diagnosis, age at testicular relapse, and concomitant relapse. Whether testicular relapse occurred on initial therapy or off initial therapy has prognostic value in predicting DFS. The 3 year DFS for boys with testicular relapse on and off initial therapy were 40.0%+/-12.9% and 78.8%+/-13.4%, respectively(P: 0.046). CONCLUSION: With the use of chemotherapy and testicular irradiation, prolonged second re mission can be achieved in many patients with testicular leukemia. The patients with testicular relapse off initial therapy fared significantly better than patients on therapy. So, to improve the DFS for boys with testicular leukemia, a better understanding of its biology and prognostic factors is needed.
Biology
;
Biopsy
;
Bone Marrow
;
Child
;
Diagnosis
;
Disease-Free Survival
;
Drug Therapy
;
Humans
;
Incidence
;
Leukemia
;
Missions and Missionaries
;
Orchiectomy
;
Pediatrics
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
;
Recurrence
;
Seoul
;
Survival Rate
;
Testis